SCLN Financial Facts

Basic net income per share: 0.13
Income from operations: 5.95M
See Full Income Statement

Goodwill: 32.25M
Additional paid-in capital: 295.77M
See Full Balance Sheet

SciClone Pharmaceuticals, Inc. (SCLN) Earnings

  |   Expand Research on SCLN
Next EPS Date 11/9/16 *Est. EPS Growth Rate -23.1% *Last Qtr.
Average EPS % Beat Rate +197.9% Revenue Growth Rate +2.9% *Last Qtr.
Average % Move 1-Wk after EPS +8.9% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/9/16 Q216 $0.20N/A N/A $39M$37.9M N/A Details
5/10/16 Q116 $0.19N/A N/A $36.5M$33.6M N/A Details
3/10/16 Q415 $0.30N/A N/A $42.9M$41.1M N/A Details
11/9/15 Q315 $0.23N/A N/A $42.9M$34.3M N/A Details
8/10/15 Q215 $0.26$0.12 +$0.14$37.9M$37.27M N/A Details
5/11/15 Q115 $0.19$0.03 +$0.16$33.6M$34M N/A Details
11/10/14 Q314 $0.17$0.12 +$0.05$34.3M$34.9M Details
8/11/14 Q214 $0.20$0.10 +$0.10$32.5M$33.4M Details